Ustekinumab 90mg/1ml solution for injection pre-filled syringes
NHS hospitals in England used £236,234,410 of indicative cost of Ustekinumab 90mg/1ml solution for injection pre-filled syringes in the 12 months to July 2026, about 0.9% of all hospital medicines spend. That is up 0.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ustekinumab 90mg/1ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ustekinumab 90mg/1ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £10,273,395 |
| University Hospital Southampton Nhs Ft | £7,754,964 |
| Guy's & St Thomas' Nhs Foundation Trust | £7,400,709 |
| Salford Royal Nhs Foundation Trust | £7,334,152 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £6,361,561 |
| Western Sussex Hospitals Nhs Found Trust | £6,121,097 |
| University College London Foundation Tr | £6,078,157 |
| Manchester University Nhs Ft | £5,586,494 |
| Barts Health Nhs Trust | £4,588,139 |
| University Hpls Of Leicester Nhs Trust | £4,521,582 |
The primary-care picture
Ustekinumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ustekinumab medicine page.